ABSTRACT: A new series of 5-(indole-2-yl)-3-substituted 1,2,4-oxadiazoles were synthesized and evaluated for their anticancer activities. Structures of the compounds were confirmed by spectroscopic methods. Structural modifications were done to improve the antiproliferative activity of compound 1. The results indicated that a benzyloxyl substituent on the C-4 position was better than a methyl substituent on the C-6 position of the indole component. Compounds 10a, 10b, 10g, 10i, 10l, 10n, 10o , and 10p were found to be more active than lead compound 1 in the PC-3 cell line. These compounds may serve as lead candidates in the development of novel chemotherapeutics for cancer treatment.
Introduction
Cancer has become the second largest cause of death in many countries (1) . Inhibition of apoptotic pathways is known as an important hallmark for cancer (2, 3) . In cancer cells, blockage of apoptosis could lead to excessive cell proliferation as well as resistance to cancer treatment. Apoptosis is caused by the activation of intracellular caspases. There are two main pathways triggering activation of caspases, referred to as the intrinsic and extrinsic pathways. Numerous cellular targets of these two pathways have been identified, such as caspases (caspase-2, -3, -6~10, and -12), B-cell lymphoma-2 (Bcl-2) family proteins (Bcl-2, Bcl-XL, Bcl-W, Bcl-B, Mcl-1, and Bfl-1), and tumor necrosis factor (TNF) family death receptors (4, 5) . It has been recently reported that several anticancer agents exhibited apoptosisinducing ability, such as imatinib, sorafenib, and lapatinib (6) (7) (8) (9) (10) . Therefore, the identifi cation of apoptosis inducers becomes an attractive approach for discovery and development of potential anticancer agents. Proapoptotic agents affected more than one target, making optimizations through structure-activity relationships (SAR) studies diffi cult (2, 11, 12) . For multiple actions of pro-apoptotic agents, screening of these agents was often based on cell line evaluation (11, 12) .
In recent years, many compounds with diverse structures were identified as pro-apoptotic agents (3, (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) . Compound 1 (Table 1) which might activate caspase-3/7 was reported as a novel 5-(indole-2-yl)-3-substituted 1,2,4-oxadiazole as a pro-apoptotic agent with anticancer activity at micromole concentrations (12) . The effects of substitution on the C-6 position of the indole ring system have been studied (12) . In order to study the SAR on other positions of the indole ring system, a series of 5-(indole-2-yl)-3-substituted 1,2,4-oxadiazoles were designed and synthesized. Their anticancer activities were tested in this paper.
Materials and Methods

Chemicals
The synthesis of intermediates 5b, 8, and 9 are shown in Scheme 1. Starting with 5-substituted salicylaldehyde (2), 5-substituted-2-benzyloxybenzaldehydes (3) were prepared by benzyl chloride in DMF catalyzed by K 2 CO 3 (22,23). Intermediates 4 were prepared by a condensation reaction between 3 and methyl 2-azidoacetate. Heating of intermediates 4 in p-xylene to refl ux for 1 h generated compounds 5 (22). Compound 6 was easily prepared from 5a by a hydrolysis reaction. Compound 6 reacted with sodium methoxide in DMF/CH 3 OH catalyzed by cuprous iodide afforded compound 7. Compound 8 was synthesized by the methylate reaction from 7 using dimethyl sulfate. The preparation of compound 9 was a methylate reaction from 5a.
The synthesis of 5-(indole-2-yl)-3-substituted 1,2,4-oxadiazoles are shown in Scheme 2. The targeting compounds were synthesized using a one-pot reaction between amidoximes (11a~11d) and substituted indoles (5b, 8, 9, 12, and 13) under microwave conditions. Compounds 12 and 13 were commercially available. 
Conclusion
In conclusion, a new series of 5-(indole-2-yl)-3-substituted 1,2,4-oxadiazoles were synthesized with cell inhibitory activities. Several compounds showed more potent activities than lead compound 1. Compounds with benzyloxyl substituent on the C-4 position had greater antiproliferative activity than those with methyl on the C-6 position of the indole component.
Compounds with both C-4 benzyloxyl and C-7 methyloxyl substituents were more effi cient than those with C-4 benzyloxyl and C-7 bromine. We successfully identifi ed compound 10b as the most active compound. Further studies based on this structure will be continued.
Cell lines
Human prostate cancer cells (PC-3) and human breast adenocarcinoma cells (MCF-7) were maintained in RPMI 1640 medium (HyClone ® , Thermo Fisher Scientific Inc., Waltham, MA, USA). The medium was supplemented with 10% fetal bovine serum (FBS) (Gibco ® , Invitrogen, Carlsbad, CA, USA), 100 μg/mL penicillin and 100 μg/mL streptomycin. Cells were cultured in a humidifi ed atmosphere of 5% CO 2 at 37°C.
MTT assay
Cells were seeded into 96-well culture plates at a density of 5 × 10 3 cells per well and cultured for 12 h. Thereafter the cells were treated with various concentrations of tested compounds and incubated for 72 h. Five mg/mL MTT solution was added to each well and the cells were incubated at 37°C for 4 h. The resulting crystals were extracted with dimethyl sulfoxide (DMSO) for 15 min. The optical density (OD) was measured using a plate microreader (Bio-Rad 680, Bio-Rad Co., Hercules, USA).
Results and Discussion
The in vitro antitumour effect of compounds 10a~10p was assessed against prostate cancer cells (PC-3) and human breast adenocarcinoma cells (MCF-7). Antiproliferative data was compared with the previously reported pro-apoptotic compound 1 as control. All inhibition results are shown in Table 1 . The PC-3 cell line was more responsive to 5-(indole-2-yl)-3-substituted 1,2,4-oxadiazoles than the MCF-7 cell line.
First we studied the single substituted indoles (R 1 , compounds 10j~10p). When comparing 10n to 10k, 10o to 10l, we found that compounds (10n and 10o) with a benzyloxyl group on the C-4 position showed more potent inhibitory activities than compounds (10k and 10l) with a methyl group on the C-6 position (IC 50 values of 21.41 and 10.52 μM for 10n and 10o, > 80 and 16.65 μM for 10k and 10l). This result showed that introduction of a benzyloxyl group on the C-4 position of the indole ring was better than a methyl group on the C-6 position.
Keeping the benzyloxyl group on the C-4 position, we introduced different substitutions on the N-1 and/or C-7 position of the indole ring leading to compounds 10a~10i. Compound 10b showed the highest inhibitory activity among these compounds (IC 50 = 8.96 μM), and was up to six times more potent than lead compound 1. Introduction of a chlorine on the 4-position of benzene ring (R 3 ) in compound 10b led to compound 10c, and the activity was decreased dramatically (IC 50 > 50 μM). Besides, compounds 10a, 10g, 10i, 10l, 10n, 10o , and 10p were found to be more active than lead compound 1 in the PC-3 cell line. They showed no activities against the MCF-7 cell line (IC 50 > 80 μM).
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Appendix
The proton nuclear magnetic resonance ( 1 H-NMR and 13 C-NMR) spectra were recorded with a Bruker Avance DRX600 instrument with tetramethylsilane (TMS) as the internal standard at 600 MHz. The chemical shifts (δ) were reported in parts per million (ppm) and were relative to the central peak of the solvent, which was DMSO-d 6 or CDCl 3 . Mass spectra (MS) were measured with an API 4000 and the high resolution mass spectra data were obtained using an Accela UPLC-LTQ Orbitrap mass spectrometer. All melting points were determined in a Büchi capillary melting point apparatus and are uncorrected. Microwave syntheses were carried out in an XH-100A Xiang Hu instrument with focused microwave heating (microwave power supply 0-1,000 W, open vessel mode). Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purifi cation. Column chromatography was carried out with silica gel using the solvents indicated. Thin-layer chromatography (TLC) was performed on silica gel GF254 plates (layer thickness, 0.2 mm), and compounds were visualized using UV light. Petroleum ether used for TLC and column chromatography had a boiling range of 60-90°C.
Synthesis of compounds 3a and 3b
To a mixture of substituted salicylaldehyde (2) (0.1 mol) and K 2 CO 3 (20.7 g, 0.15 mol) in DMF (100 mL), benzyl chloride (19.0 g, 0.15 mol) was added dropwise. Then the mixture was heated to 60°C for 8 h. After being allowed to cool to r.t., the mixture was poured into ice-water (1,000 mL). The precipitate was fi ltered, washed several times with water, and further purified by recrystallization in ethanol to afford 3. 
2-(Benzyloxy)-5-bromobenzaldehyde (3a)
Yield
Synthesis of compounds 4a and 4b
To a cooled (−20°C) solution of 3 (0.05 mol) and methyl 2-azidoacetate (23.0 g, 0.2 mol) in anhydrous CH 3 OH (75 mL) and THF (45 mL) under a N 2 atmosphere, was added a solution of CH 3 ONa (10.8 g, 0.2 mol) in anhydrous CH 3 OH (30 mL) dropwise over 1 h, maintaining the temperature below −17°C. After 4 h, the mixture was placed in an ice-bath overnight. Cooled CH 3 OH (50 mL) was added into the mixture and then the precipitate was filtered, and washed twice with CH 3 OH to get compounds 4.
(
Z ) -M e t h y l 2 -a z i d o -3 -( 2 -( b e n z y l o x y ) -5 -bromophenyl)acrylate (4a)
Yellow solid, yield 70%, mp 88.9-90.1°C. 
Synthesis of compounds 5a and 5b
Compounds 4 were suspended in p-xylene (400 mL). The mixture was heated to 150°C for 4 h. After being allowed to cool to r.t., the crude product precipitated was collected by filtration, and further purified by recrystallization in ethyl acetate/petroleum ether to afford 5. 
Methyl 4-(benzyloxy)-7-bromo-1H-indole-2-carboxylate (5a)
4-(Benzyloxy)-7-bromo-1H-indole-2-carboxylic acid (6)
A solution of 5a (3.6 g, 10 mmol), KOH (2.24 g, 40 mmol) in THF (40 mL) and water (15 mL) was heated to reflux for 4 h. After cooling to r.t., the THF was evaporated under reduced pressure. The mixture was poured into water and acidifi ed with aq HCl (6N) to pH 1-2. The precipitate was fi ltered, washed several times with water, and further purifi ed by recrystallization in ethyl acetate/petroleum ether to afford 6. Yield 3.29 g (95%); white power; mp 248.6-249.8°C. 
4-(Benzyloxy)-7-methoxy-1H-indole-2-carboxylic acid (7)
A mixture of 6 (3.46 g, 10 mmol), CuI (1.9 g, 10 mmol), CH 3 ONa (3.8 g, 70 mmol) in anhydrous CH 3 OH (20 mL) and DMF (40 mL) under N 2 atmosphere was heated and refluxed for 5 h. After cooling to r.t., the mixture was poured into water (500 mL) and acidifi ed with aq HCl (6N) to pH 1-2 
Methyl 4-(benzyloxy)-7-bromo-1-methyl-1H-indole-2-carboxylate (9)
The procedure was the same as compound 7 to 8. Yield 3.39 g (91%); colorless crystal; mp 108.6-109.9°C. 
General procedure for synthesis of 10a~10p under microwave irradiation
Substituted indole-based carboxylic acid esters (5b, 8, 9, 12, and 13) (1 mmol), amidoximes (2 mmol) and cesium carbonate (0.65 g, 2 mmol) in DMF (5 mL) were placed in a 10 mL flask followed by microwave irradiation (800 W, 150°C) for the desired time. After cooling to r.t., the mixture was poured into 100 mL cold water, and then extracted with ethyl acetate. The combined organic solvent was dried over Na 2 SO 4 , filtered, and concentrated in vacuum. The crude product was purifi ed by silica-gel chromatography with petroleum ether-ethyl acetate (15:1) to give the desired compounds 10a~10p. Yield  60% ; white powder; mp 198.2-199.5°C. 
5-(4-(
5-(4-(Benzyloxy)-7-methoxy-1-methyl-1H-indol-2-yl)-3-(4-chlorophenyl)-1,2,4-oxadiazole (10c)
